Prevalence and risk factors for recovery of filamentous fungi in individuals with cystic fibrosis
Christopher R. Sudfeld(Harvard University), Michael Boyle(McMaster University), William G. Merz(University of California San Diego), Karen C. Carroll(Johns Hopkins University), Elliott C. Dasenbrook(Cleveland Clinic)
Cited by 130
Related Papers
Update on Key Emerging Challenges in Cystic Fibrosis
|Medical Principles and Practice|2014|3.7k
Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA)
|Clinical Infectious Diseases|2017|2.7k
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del<i>CFTR</i>
|New England Journal of Medicine|2015|1.6k